Profile data is unavailable for this security.
About the company
Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.
- Revenue in AUD (TTM)1.69bn
- Net income in AUD-984.10m
- Incorporated1994
- Employees10.50k
- LocationHealius LtdLevel 22Liberty Place, 161 Castlereagh StreetSYDNEY 2000AustraliaAUS
- Phone+61 29432-9400
- Fax+61 29432-9447
- Websitehttps://www.healius.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Capitol Health Ltd | 229.29m | 6.14m | 266.51m | -- | 43.55 | 1.99 | 8.09 | 1.16 | 0.0057 | 0.0057 | 0.214 | 0.1256 | 0.7237 | -- | 47.34 | -- | 1.97 | 3.05 | 2.27 | 3.55 | 92.94 | 92.41 | 2.73 | 4.24 | -- | -- | 0.5219 | 130.91 | 13.81 | 11.90 | -203.87 | -- | 19.92 | 4.56 |
Australian Unity Ltd | 2.00bn | 43.47m | 280.73m | 7.70k | -- | -- | 2.89 | 0.1405 | -- | -- | -- | -- | 0.2346 | -- | -- | 259,666.80 | 0.5105 | 0.5917 | -- | -- | -- | -- | 2.18 | 2.65 | -- | 2.25 | 0.6373 | -- | 36.50 | 12.70 | 24.19 | -- | -5.72 | -- |
Pacific Smiles Group Ltd | 173.72m | 6.61m | 304.00m | 800.00 | 43.50 | 5.05 | 8.07 | 1.75 | 0.0438 | 0.0438 | 1.09 | 0.3774 | 0.9257 | 3.88 | 57.63 | -- | 3.52 | 3.61 | 4.44 | 4.55 | 86.25 | 85.00 | 3.80 | 3.68 | 0.5689 | 2.95 | 0.5862 | 78.81 | 18.54 | 9.60 | 153.43 | -18.18 | -4.27 | -15.55 |
Australian Clinical Labs Ltd | 674.03m | 15.43m | 468.25m | 5.12k | 30.26 | 2.82 | 3.32 | 0.6947 | 0.0767 | 0.0767 | 3.35 | 0.8221 | 1.14 | 6.77 | 9.12 | 131,774.80 | 2.65 | 15.43 | 3.92 | 24.15 | 82.75 | 81.10 | 2.32 | 9.32 | 0.5735 | 2.89 | 0.6646 | 44.29 | -29.99 | 12.95 | -79.86 | -- | -4.29 | -- |
Monash IVF Group Ltd | 235.97m | 23.97m | 563.02m | 867.00 | 23.65 | 2.04 | 13.71 | 2.39 | 0.0611 | 0.0611 | 0.6014 | 0.7095 | 0.5572 | 3.88 | 13.19 | 272,169.60 | 5.67 | 5.66 | 6.74 | 6.33 | 89.52 | 89.40 | 10.17 | 11.02 | 0.2846 | 9.63 | 0.3024 | 68.46 | 11.07 | 7.23 | 18.65 | 0.4511 | 33.48 | -4.72 |
Integral Diagnostics Ltd | 456.31m | -57.85m | 580.23m | 2.00k | -- | 1.93 | -- | 1.27 | -0.2485 | -0.2485 | 1.94 | 1.29 | 0.5758 | 13.71 | 21.44 | 228,157.00 | -7.30 | 4.02 | -8.19 | 4.55 | 95.23 | 95.17 | -12.68 | 6.92 | 0.7415 | 2.04 | 0.5462 | 70.64 | 22.13 | 18.36 | 71.47 | 10.68 | 30.60 | -5.01 |
Healius Ltd | 1.69bn | -984.10m | 911.26m | 10.50k | -- | 0.8676 | -- | 0.5386 | -1.45 | -1.43 | 2.53 | 1.45 | 0.4782 | 6.27 | 9.78 | 161,123.80 | -27.81 | 0.6198 | -33.52 | 0.7441 | 87.07 | 86.75 | -58.17 | 1.32 | 0.4713 | 1.07 | 0.606 | 195.89 | -25.43 | 0.027 | -229.96 | -- | -5.86 | -- |
Regis Healthcare Ltd | 950.89m | -14.68m | 1.24bn | 9.00k | -- | 269.85 | 11.10 | 1.30 | -0.0488 | -0.0488 | 3.16 | 0.0152 | 0.5274 | -- | 45.73 | 105,654.40 | -0.8145 | 0.0329 | -10.71 | 0.149 | -- | -- | -1.54 | 0.0763 | 0.0716 | -- | 0.9412 | 3,882.96 | 7.16 | 7.27 | 26.67 | -- | -25.03 | -11.97 |
Holder | Shares | % Held |
---|---|---|
Perpetual Investment Management Ltd.as of 06 May 2024 | 105.18m | 14.49% |
Australian Retirement Trust Pty Ltd.as of 20 Mar 2024 | 72.19m | 9.94% |
Maple-Brown Abbott Ltd.as of 27 Dec 2023 | 34.98m | 4.82% |
Dimensional Fund Advisors LPas of 31 Aug 2023 | 32.94m | 4.54% |
The Vanguard Group, Inc.as of 31 Aug 2023 | 31.34m | 4.32% |
First Sentier Investors (Australia) IM Ltd.as of 05 Feb 2024 | 30.56m | 4.21% |
Colonial First State Investments Ltd.as of 25 Sep 2023 | 30.33m | 4.18% |
State Street Global Advisors, Australia, Ltd.as of 03 Nov 2023 | 26.10m | 3.60% |
Argo Investments Ltd. (Investment Management)as of 31 Aug 2023 | 20.67m | 2.85% |
Wilson Asset Management (International) Pty Ltd.as of 30 Jun 2023 | 13.53m | 1.86% |